192 related articles for article (PubMed ID: 33989509)
1. Examining unsafe injection practices associated with auto-disable (AD) syringes: a systematic review.
Ali Khan A; Munir M; Miraj F; Imran S; Arif Siddiqi D; Altaf A; Khan AJ; Chandir S
Hum Vaccin Immunother; 2021 Sep; 17(9):3247-3258. PubMed ID: 33989509
[TBL] [Abstract][Full Text] [Related]
2. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China.
Murakami H; Kobayashi M; Zhu X; Li Y; Wakai S; Chiba Y
Soc Sci Med; 2003 Nov; 57(10):1821-32. PubMed ID: 14499508
[TBL] [Abstract][Full Text] [Related]
3. Hidden reality on the introduction of auto-disable syringes in developing countries.
Kuroiwa C; Suzuki A; Yamaji Y; Miyoshi M
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1019-23. PubMed ID: 15916108
[TBL] [Abstract][Full Text] [Related]
4. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme.
Steinglass R; Boyd D; Grabowsky M; Laghari AG; Khan MA; Qavi A; Evans P
Bull World Health Organ; 1995; 73(1):57-63. PubMed ID: 7704926
[TBL] [Abstract][Full Text] [Related]
5. Use of SoloShot autodestruct syringes compared with disposable syringes, in a national immunization campaign in Indonesia.
Nelson CM; Sutanto A; Suradana IG
Bull World Health Organ; 1999; 77(1):29-33. PubMed ID: 10063658
[TBL] [Abstract][Full Text] [Related]
6. Measles supplementary immunization activities and GAVI funds as catalysts for improving injection safety in Africa.
Hoekstra EJ; van den Ent MM; Dao H; Khalaf H; Salovaara A
J Infect Dis; 2011 Jul; 204 Suppl 1():S190-7. PubMed ID: 21666161
[TBL] [Abstract][Full Text] [Related]
7. Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.
Aylward B; Lloyd J; Zaffran M; McNair-Scott R; Evans P
Bull World Health Organ; 1995; 73(4):531-40. PubMed ID: 7554027
[TBL] [Abstract][Full Text] [Related]
8. Introducing auto-disable syringes to the national immunization programme in Madagascar.
Drain PK; Ralaivao JS; Rakotonandrasana A; Carnell MA
Bull World Health Organ; 2003; 81(8):553-60. PubMed ID: 14576886
[TBL] [Abstract][Full Text] [Related]
9. Reuse prevention syringes for reconstitution of lyophilized vaccines: Operational study and UNICEF plans for expanding introduction.
Fleming JA; Hoekstra EJ; Moniaga V; Widjaya A; Soepardi J; Supartha N; Salovaara A; Khamassi S; Nelson C
Int J Occup Environ Health; 2009; 15(1):9-13. PubMed ID: 19267121
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.
Reid S
Indian J Community Med; 2012 Apr; 37(2):89-94. PubMed ID: 22654281
[TBL] [Abstract][Full Text] [Related]
11. An assessment of safe injection practices in health facilities in Swaziland.
Daly AD; Nxumalo MP; Biellik RJ
S Afr Med J; 2004 Mar; 94(3):194-7. PubMed ID: 15098279
[TBL] [Abstract][Full Text] [Related]
12. Disposable insulin syringe reuse and aseptic practices in diabetic patients.
Thomas DR; Fischer RG; Nicholas WC; Beghe C; Hatten KW; Thomas JN
J Gen Intern Med; 1989; 4(2):97-100. PubMed ID: 2651607
[TBL] [Abstract][Full Text] [Related]
13. Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: validation of a survey instrument that probes for specific misconceptions.
Okwen MP; Ngem BY; Alomba FA; Capo MV; Reid SR; Ewang EC
Harm Reduct J; 2011 Feb; 8():4. PubMed ID: 21299899
[TBL] [Abstract][Full Text] [Related]
14. Reuse of syringes for therapeutic injections in Pakistan: rethinking determinants.
Khan A; Altaf A; Qureshi H; Orakzai M; Khan A
East Mediterr Health J; 2020 Mar; 26(3):283-289. PubMed ID: 32281637
[TBL] [Abstract][Full Text] [Related]
15. Patient Notification Events Due to Syringe Reuse and Mishandling of Injectable Medications by Health Care Personnel-United States, 2012-2018: Summary and Recommended Actions for Prevention and Response.
Schaefer MK; Perkins KM; Perz JF
Mayo Clin Proc; 2020 Feb; 95(2):243-254. PubMed ID: 31883694
[TBL] [Abstract][Full Text] [Related]
16. Rapid assessment of injection practices in Cambodia, 2002.
Vong S; Perz JF; Sok S; Som S; Goldstein S; Hutin Y; Tulloch J
BMC Public Health; 2005 Jun; 5():56. PubMed ID: 15929800
[TBL] [Abstract][Full Text] [Related]
17. Safe and newer injection technologies.
Sharma S
J Indian Med Assoc; 2005 Apr; 103(4):215-6, 218, 221. PubMed ID: 16173428
[TBL] [Abstract][Full Text] [Related]
18. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries.
Drain PK; Nelson CM; Lloyd JS
Bull World Health Organ; 2003; 81(10):726-31. PubMed ID: 14758432
[TBL] [Abstract][Full Text] [Related]
19. Auto-disable syringes for immunization: issues in technology transfer.
Lloyd JS; Milstien JB
Bull World Health Organ; 1999; 77(12):1001-7. PubMed ID: 10680248
[TBL] [Abstract][Full Text] [Related]
20. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections.
Aylward B; Kane M; McNair-Scott R; Hu DJ; Hu DH
Int J Epidemiol; 1995 Apr; 24(2):446-52. PubMed ID: 7635609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
